case_images: PMC8312323_01
case_images: Medication strategy and disease conditions of the patient during the treatment. (A) An illustrated summary of the treatment received by the patient. (B) Course of tumor markers (carcinoembryonic antigen (CEA)) while receiving treatment.
case_images: OTT-14-4261-g0001.jpg
case_images: PMC8312323_01_OTT-14-4261-g0001.jpg
case_images: f0001
case_images: A 77-year-old man was diagnosed with stage IV (T1N3M1) lung ADC with right middle lobe, right-sided pleural effusion and multiple bone metastasis in June 2016 (Figure 1A). The patient achieved a stable disease (SD) of lung lesion, but a remarkable elevated level of serum carcinoembryonic antigen (CEA) was found (Figure 1B).